June 21, 2018

Cannabis products: the future for epilepsy and other conditions

The case of Billy Caldwell has grabbed the attention of the country as debates have raged around whether cannabis should be legalised, if cannabis products should be available on the NHS, who should have the final say on medical matters and whether the UK has the right approach to illegal drugs. A lot of this debate assumes that cannabis and its products have an important role in modern medicine, and epilepsy in particular, but the science is not that straightforward.

Speakers:

Prof Helen Cross, The Prince of Wales’s Chair of Childhood Epilepsy and Honorary Consultant in Paediatric Neurology at UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust

Prof Valerie Curran, Director, Clinical Psychopharmacology Unit, UCL

Dr Amir Englund, Researcher in Psychosis Studies, King’s College London’s Institute of Psychiatry, Psychology & Neuroscience

Dr Sagnik Bhattacharyya, Reader in Translational Neuroscience and Psychiatry,  King’s College London’s Institute of Psychiatry, Psychology & Neuroscience